Concepedia

N. Parmar

NP

16

Publications

611

Citations

13

H-Index

2014

Active since

Affiliations

Central Drug Research Institute(Current)

Academy of Scientific and Innovative Research

Norwegian University of Science and Technology

University of Toronto

Council of Scientific and Industrial Research

N. Parmar is an author at Central Drug Research Institute specializing in medicine, immunology, and pharmacology.

ORCID

Top concepts

Publications per year

2014–2024

16

Publications

16

Acetylcholine production by group 2 innate lymphoid cells promotes mucosal immunity to helminths

Luke B. Roberts, Corinna Schnoeller, Rita Berkachy et al. · Science Immunology · 2021 · 89 citations · Full text

Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine

Devireddy Anand, Pawan Kumar Yadav, Om Prakash Patel et al. · Journal of Medicinal Chemistry · 2017 · 88 citations

, , +21

BMP signaling in the intestinal epithelium drives a critical feedback loop to restrain IL-13–driven tuft cell hyperplasia

Håvard T. Lindholm, N. Parmar, Claire Drurey et al. · Science Immunology · 2022 · 62 citations

Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis

Akanksha Upadhyay, Pragya Chandrakar, Sampa Gupta et al. · Journal of Medicinal Chemistry · 2019 · 56 citations

<i>Leishmania donovani</i> Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization

N. Parmar, Pragya Chandrakar, S.K. Kar · The Journal of Immunology · 2020 · 46 citations

Rows per page

1–5 of 16